Court stays Religare AGM, RBI’s nod for open offer

In a setback to the Burman family, the Madhya Pradesh High Court has stayed the approval granted by the Reserve Bank of India (RBI) for making an open offer to acquire an additional 26% stake in Religare Enterprises as well as the company’s annual general meeting (AGM) scheduled for December 31.

Earlier this month, RBI approved the open offer of the Burman family, which currently holds a 25% stake in Religare through its four entities, to acquire an additional 26%, potentially gaining majority control of the NBFC.

Also ReadReliance Power arm gets interim relief from HC against SECI order

The AGM gains importance as Religare chairperson Rashmi Saluja is up for reappointment, which had already been pushed to December from September. The Burmans, proxy firm InGovern, as well as certain institutional investors have called for voting Saluja out against her fresh five-year term for on the Religare board.

“Till further orders, the notice dated December 9, 2024 (RBI approval) and the Annual General Body Meeting of Respondent No. 7 (Religare Enterprises) which is scheduled to be held on December 31, 2024 shall remained stayed,” Madhya Pradesh High Court said in its order.

The matter will be next heard after four weeks, tentatively on January 17.

The order passed by a division bench of chief justice Suresh Kumar Kait and justice Vivek Jain was in response to a public interest litigation filed by Madhya Pradesh-based advocate Vijayant Mishra, representing the interest of Religare’s minority shareholders.

Mishra’s plea said if the open offer goes through and the four companies consolidate as per RBI’s condition, the control will fall in the hands of only 399 persons, affecting the shareholding of 73,263 persons who hold up to Rs 2 lakh worth of shares in Religare.

Also ReadEatSure becomes first platform to launch multi-restaurant ordering

He has requested the court to set up an independent commission of enquiry to oversee and monitor the proposed acquisition of Religare to protect the minority shareholders’ interest.

This court order further elongates the dispute between the Religare management and the Burmans, spanning over one-and-a-half years now. It started in September last year when the Burmans had announced acquiring additional stake in the NBFC through a Rs 2,116-crore open offer. The offer was contested by the Religare management,

 » Read More

Related Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs. 3,230 Cr, up by 24% YoY and domestic revenue at INR 2,773 Cr, up 17%, Exports at INR 457 Cr, up 121% YoY. The company’s